Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinainu in pediatric alopecia areata
NCT03240627Phase 3Completed
- Sponsor
- Legacy Healthcare
- Start
- Feb 2018
- Primary completion
- Mar 2022
- Modality
- Botanical drug
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in alopecia areata comparing Cinainu with Placebo (2 arms). Primary endpoint: Relative change in scalp alopecia areata severity scores (SALT) from baseline at 24 weeks. Started Feb 2018; status: completed.
02
Drugs
Cinainu
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT03240627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03240627.